SEC Filings
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Filing | Description | Date Filed  |
Size | View | ||||
|---|---|---|---|---|---|---|---|---|
| 8-K | current report | May 21, 2013 | 27.0 KB |
|
||||
| 10-Q | quarterly report | May 9, 2013 | 767.2 KB |
|
||||
| 8-K | current report | May 9, 2013 | 107.3 KB |
|
||||
| DEFA14A | definitive proxy statement | May 6, 2013 | 188.0 KB |
|
||||
| DEFA14A | definitive proxy statement | May 6, 2013 | 114.6 KB |
|
||||
| DEF 14A | definitive proxy statement | Apr 30, 2013 | 809.3 KB |
|
||||
| 3 | turgeon joseph w. | Apr 24, 2013 | 25.5 KB |
|
||||
| 3 | allen lee f md phd | Apr 24, 2013 | 25.0 KB |
|
||||
| CT ORDER | confidential treatment order | Mar 26, 2013 | 9.3 KB |
|
||||
| 8-K | current report | Mar 14, 2013 | 68.9 KB |
|
||||
| 8-K | current report | Mar 12, 2013 | 63.2 KB |
|
||||
| 4 | maida, anthony e iii | Mar 5, 2013 | 26.6 KB |
|
||||
| 10-K | annual report | Feb 28, 2013 | 1.6 MB |
|
||||
| 8-K | current report | Feb 21, 2013 | 124.5 KB |
|
||||
| 5 | shrotriya rajesh c md | Feb 14, 2013 | 31.3 KB |
|
||||
| SC 13G/A | amended statement of beneficial ownership | Feb 14, 2013 | 29.0 KB |
|
||||
| SC 13G/A | amended statement of beneficial ownership | Feb 14, 2013 | 43.6 KB |
|
||||
| SC 13G | statement of beneficial ownership | Feb 11, 2013 | 27.2 KB |
|
||||
| 4 | maida, anthony e iii | Feb 6, 2013 | 28.1 KB |
|
||||
| SC 13G/A | amended statement of beneficial ownership | Feb 1, 2013 | 26.3 KB |
|
||||
|
||||||||
NASDAQ: SPPI
Provided by eSignal.
Shareholder Tools
Search IR
This Web site contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and in reliance upon the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are based on the beliefs of the Company's management as well as assumptions made by and information currently available to the Company's management. Readers should not put undue reliance on these forward-looking statements. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Spectrum Pharmaceuticals, Inc.'s actual results may differ materially from the results projected in the forward-looking statements. Factors that might cause such a difference include, but are not limited to, those discussed in the Company's most recent Form 10-K and 10-Qs. We do not plan to update any such forward-looking statements and expressly disclaim any duty to update the information contained in this filing except as required by law.
 |
All contents copyright Spectrum Pharmaceuticals, Inc. © 2013. All Rights Reserved. 1451-042000 |
Site Map | Privacy Policy | Terms of Use | Linking Policy Contact Us | New Webmail | Legacy Webmail |